US Plans For End Of Covid-19 Shot, Treatment Coverage - WSJ
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
Pfizer (PFE) Ordered by FDA to Test Impact of Repeat Course of Paxlovid - BBG
August 19, 2022 3:48 PM EDTUS regulators ordered Pfizer (NYSE: PFE) to test the impact of an extra course of Paxlovid in people who experience a rebound in Covid-19 following treatment, Bloomberg reported Friday.
Bloomberg stated the drug will go through a further study after reports of the "mysterious phenomenon" continue to rise.... More
Moderna (MRNA), Pfizer (PFE) on Watch Following Report U.S. Plans for End of Coverage for Covid Shots, Treatments
August 18, 2022 12:03 PM EDTModerna (NASDAQ: MRNA), Pfizer (NYSE: PFE) on Watch Following Report U.S. Plans for End of Coverage for Covid Shots, Treatments
... More


